The article provides pathogenetic justification of the need and the effectiveness of enzyme replacement therapy (ERT) of postcholecystectomy syndrome (PHES) in children. Special focus will be on the possibility of using the ERT in PHES in children of different age groups. Personal experience with these drugs in children with cholelithiasis is provided, considering their mechanism of action and side effects of ERT. Advantages of Creon are demonstrated for correction of exocrine pancreatic function in PHES in children.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
phes children
12
postcholecystectomy syndrome
8
[enzyme therapy
4
therapy postcholecystectomy
4
syndrome children]
4
children] article
4
article pathogenetic
4
pathogenetic justification
4
justification effectiveness
4
effectiveness enzyme
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!